Takara Bio Inc. announced that it has reached a distribution agreement with Nippi Inc. to distribute recombinant Laminin 511-E8 fragments (iMatrix-511), which will become available for sale in Japan on July 16th, 2013. The product will be also supplied outside Japan through Takara Bio's sales network.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,810 JPY | +1.04% | +0.17% | -2.52% |
1st Jan change | Capi. | |
---|---|---|
-2.52% | 11Cr | |
+13.74% | 829Cr | |
+5.29% | 761.21Cr | |
-0.42% | 596.02Cr | |
-6.67% | 372.06Cr | |
-10.75% | 361.33Cr | |
-8.21% | 129.58Cr | |
-29.10% | 107.47Cr | |
+14.92% | 99Cr | |
-12.46% | 89Cr |
- Stock Market
- Equities
- 7932 Stock
- News Nippi,Incorporated
- Takara Bio Inc. Reaches Distribution Agreement with Nippi Inc